Mereo BioPharma Group plc (MPH.L) (LON:MPH) Stock Passes Below Fifty Day Moving Average of $26.50

Mereo BioPharma Group plc (MPH.L) (LON:MPH) passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 26.50 ($0.33) and traded as low as GBX 26 ($0.32). Mereo BioPharma Group plc (MPH.L) shares last traded at GBX 26.50 ($0.33), with a volume of 49,264 shares.

Mereo BioPharma Group plc (MPH.L) Stock Down 1.9 %

The company has a debt-to-equity ratio of 164.26, a quick ratio of 2.92 and a current ratio of 2.98. The firm has a market capitalization of £89.76 million and a PE ratio of -0.21. The company’s 50 day simple moving average is GBX 26.50 and its 200-day simple moving average is GBX 26.50.

Mereo BioPharma Group plc (MPH.L) Company Profile

Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor.